GEN — Genomed SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN31.71m
- PLN26.47m
- PLN23.01m
- 92
- 29
- 20
- 41
Annual cashflow statement for Genomed SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | PAS | PAS | PAS | PAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.412 | 1.24 | 0.338 | 0.926 | 1.11 |
| Depreciation | |||||
| Non-Cash Items | -0.067 | 0.028 | — | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.837 | 0.179 | -1.42 | 0.422 | -0.213 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.89 | 2.21 | -0.356 | 1.97 | 1.64 |
| Capital Expenditures | -1.01 | -0.516 | -0.246 | -0.204 | -1.67 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -1.01 | -0.516 | -0.246 | -0.204 | -1.67 |
| Financing Cash Flow Items | 0.795 | -0.002 | -0.064 | -0.015 | -0.005 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.722 | -1.26 | -0.829 | 0.01 | 0.008 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.61 | 0.436 | -1.43 | 1.77 | -0.019 |